OBO ID: DOID:11723

Citations

(23 total)

Term: Duchenne muscular dystrophy

Terrill, J.R., Huchet, C., Le Guiner, C., Lafoux, A., Caudal, D., Tulangekar, A., Bryson-Richardson, R.J., Sztal, T.E., Grounds, M.D., Arthur, P.G. (2023) Muscle Pathology in Dystrophic Rats and Zebrafish Is Unresponsive to Taurine Treatment, Compared to the mdx Mouse Model for Duchenne Muscular Dystrophy. Metabolites. 13(2):

English, K.G., Reid, A.L., Samani, A., Coulis, G.J.F., Villalta, S.A., Walker, C.J., Tamir, S., Alexander, M.S. (2022) Next-Generation SINE Compound KPT-8602 Ameliorates Dystrophic Pathology in Zebrafish and Mouse Models of DMD. Biomedicines. 10(10):

Kilroy, E.A., Ignacz, A.C., Brann, K.L., Schaffer, C.E., Varney, D., Alrowaished, S.S., Silknitter, K.J., Miner, J.N., Almaghasilah, A., Spellen, T.L., Lewis, A.D., Tilbury, K., King, B.L., Kelley, J.B., Henry, C.A. (2022) Beneficial impacts of neuromuscular electrical stimulation on muscle structure and function in the zebrafish model of Duchenne muscular dystrophy. eLIFE. 11:

Licitra, R., Marchese, M., Brogi, L., Fronte, B., Pitto, L., Santorelli, F.M. (2021) Nutraceutical Screening in a Zebrafish Model of Muscular Dystrophy: Gingerol as a Possible Food Aid. Nutrients. 13(3):

Spreafico, M., Cafora, M., Bragato, C., Capitanio, D., Marasca, F., Bodega, B., De Palma, C., Mora, M., Gelfi, C., Marozzi, A., Pistocchi, A. (2021) Targeting HDAC8 to ameliorate skeletal muscle differentiation in Duchenne muscular dystrophy. Pharmacological research. 170:105750

Lambert, M.R., Spinazzola, J.M., Widrick, J.J., Pakula, A., Conner, J.R., Chin, J.E., Owens, J.M., Kunkel, L.M. (2020) PDE10A inhibition reduces the manifestation of pathology in DMD zebrafish and represses the genetic modifier PITPNA. Molecular therapy : the journal of the American Society of Gene Therapy. 29(3):1086-1101

Lasa-Fernandez, H., Mosqueira-Martín, L., Alzualde, A., Lasa-Elgarresta, J., Vallejo-Illarramendi, A. (2020) A genotyping method combining primer competition PCR with HRM analysis to identify point mutations in Duchenne animal models. Scientific Reports. 10:17224

Spinazzola, J.M., Lambert, M.R., Gibbs, D.E., Conner, J.R., Krikorian, G.L., Pareek, P., Rago, C., Kunkel, L.M. (2020) Effect of serotonin modulation on dystrophin-deficient zebrafish. Biology Open. 9(8):

Hightower, R.M., Reid, A.L., Gibbs, D.E., Wang, Y., Widrick, J.J., Kunkel, L.M., Kastenschmidt, J.M., Villalta, S.A., van Groen, T., Chang, H., Gornisiewicz, S., Landesman, Y., Tamir, S., Alexander, M.S. (2019) The SINE Compound KPT-350 Blocks Dystrophic Pathologies in DMD Zebrafish and Mice. Molecular therapy : the journal of the American Society of Gene Therapy. 28(1):189-201

Varga, M., Ralbovszki, D., Balogh, E., Hamar, R., Keszthelyi, M., Tory, K. (2018) Zebrafish Models of Rare Hereditary Pediatric Diseases. Diseases (Basel, Switzerland). 6(2)

Bajanca, F., Vandel, L. (2017) Epigenetic Regulators Modulate Muscle Damage in Duchenne Muscular Dystrophy Model. PLoS Currents. 9

Goody, M., Jurczyszak, D., Kim, C., Henry, C. (2017) Influenza A Virus Infection Damages Zebrafish Skeletal Muscle and Exacerbates Disease in Zebrafish Modeling Duchenne Muscular Dystrophy. PLoS Currents. 9

Schiavone, M., Zulian, A., Menazza, S., Petronilli, V., Argenton, F., Merlini, L., Sabatelli, P., Bernardi, P. (2017) Alisporivir rescues defective mitochondrial respiration in Duchenne muscular dystrophy. Pharmacological research. 125(Pt B):122-131

Lipscomb, L., Piggott, R.W., Emmerson, T., Winder, S.J. (2016) Dasatinib as a treatment for Duchenne muscular dystrophy. Human molecular genetics. 25(2):266-74

Sztal, T.E., Ruparelia, A.A., Williams, C., Bryson-Richardson, R.J. (2016) Using Touch-evoked Response and Locomotion Assays to Assess Muscle Performance and Function in Zebrafish. Journal of visualized experiments : JoVE. (116)

Widrick, J.J., Alexander, M., Sanchez, B., Gibbs, D., Kawahara, G., Beggs, A., Kunkel, L. (2016) Muscle dysfunction in a zebrafish model of Duchenne muscular dystrophy. Physiological Genomics. 48(11):850-860

Plantié, E., Migocka-PatrzaBek, M., Daczewska, M., Jagla, K. (2015) Model Organisms in the Fight against Muscular Dystrophy: Lessons from Drosophila and Zebrafish. Molecules. 20:6237-6253

Vieira, N.M., Elvers, I., Alexander, M.S., Moreira, Y.B., Eran, A., Gomes, J.P., Marshall, J.L., Karlsson, E.K., Verjovski-Almeida, S., Lindblad-Toh, K., Kunkel, L.M., Zatz, M. (2015) Jagged 1 Rescues the Duchenne Muscular Dystrophy Phenotype. Cell. 163:1204-13

Vågberg, W., Larsson, D.H., Li, M., Arner, A., Hertz, H.M. (2015) X-ray phase-contrast tomography for high-spatial-resolution zebrafish muscle imaging. Scientific Reports. 5:16625

Li, M., Andersson-Lendahl, M., Sejersen, T., and Arner, A. (2014) Muscle dysfunction and structural defects of dystrophin-null sapje mutant zebrafish larvae are rescued by ataluren treatment. FASEB journal : official publication of the Federation of American Societies for Experimental Biology. 34(Suppl2):116-122

Johnson, N.M., Farr, G.H., and Maves, L. (2013) The HDAC Inhibitor TSA Ameliorates a Zebrafish Model of Duchenne Muscular Dystrophy. PLoS Currents. 5:157-71

Kawahara, G., Karpf, J.A., Myers, J.A., Alexander, M.S., Guyon, J.R., and Kunkel, L.M. (2011) Drug screening in a zebrafish model of Duchenne muscular dystrophy. Proceedings of the National Academy of Sciences of the United States of America. 108(13):5331-6

Bassett, D., and Currie, P.D. (2004) Identification of a zebrafish model of muscular dystrophy. Clinical and experimental pharmacology & physiology. 31(8):537-540